ARCHIVES

In Brief: Congress Asked To Investigate Dieldrin Danger; Harvard’s Rosenberg To Be NCI Surgery Chief

This article is from The Cancer Letter archive.

Vol. 01 No. 09 | April 5, 1974

Download PDF Visit The Full Archive

Related Articles

BMS Settles Charges Of Obstructing Generics

March 14, 2003

Jako Bows Out with Blast At NCI, Calls For IOM Review Of Cancer Program

April 15, 1988

Adding Topotecan To Standard Treatment Doesn’t Improve Progression-Free Survival

October 29, 2010

Center Program Move Definite; DCBD to Be Renamed

September 22, 1989

Clinical Trials: Data Manager Falsified NSABP Records On 3 Patients, ORI Says

February 12, 1999

Montefore Oncology Dept. Writes In Support of Peter Wiernik

November 12, 1993